ECHA Begins Consultation Identifying BPF, BPAF, and Eight BPAF Salts as Endocrine Disruptors

The European Chemicals Agency (ECHA) published an item in its May 11, 2022, ECHA Weekly announcing that it is launching consultations to support the Member State Committee (MSC) in adopting an opinion on whether 4,4’-methylenediphenol (BPF), 4,4’-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol (BPAF), and eight BPAF salts meet the criteria for endocrine disrupting substances for the environment, as defined by the World Health Organization (WHO)/International Program on Chemical Safety (IPCS) (2002). The substances have not been identified as substances of very high concern (SVHC). The German Competent Authority indicated through an entry on the Registry of Intentions that it intends to submit in October 2022 a proposal to restrict these substances. Comments are due June 20, 2022.